[EN] HOMOPIPERAZINYL AND HOMOPIPERIDINYL QUINAZOLIN-4(3H)-ONE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN [FR] DÉRIVÉS D'HOMOPIPÉRAZINYLE ET D'HOMOPIPÉRIDINYLE QUINAZOLIN-4(3H)-ONE POSSÉDANT UNE ACTIVITÉ PLURIMODALE CONTRE LA DOULEUR
[EN] HOMOPIPERAZINYL AND HOMOPIPERIDINYL QUINAZOLIN-4(3H)-ONE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN<br/>[FR] DÉRIVÉS D'HOMOPIPÉRAZINYLE ET D'HOMOPIPÉRIDINYLE QUINAZOLIN-4(3H)-ONE POSSÉDANT UNE ACTIVITÉ PLURIMODALE CONTRE LA DOULEUR
申请人:ESTEVE PHARMACEUTICALS SA
公开号:WO2021069339A1
公开(公告)日:2021-04-15
The present invention relates to homopiperazinyl and homopiperidinyl quinazolin- 4(3H)-one derivatives having dual pharmacological activity towards both the α2δ subunit of the voltage-gated calcium channel and the sigma-1 (σ1) receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.